FGF401 induces tumor regression in high FGF19-expressing HCC models by modulating FGF19/FGFR-4 signaling, inhibiting proliferation, inducing apoptosis, and inhibiting hypoxia via blood vessel normalization, and this effect was further enhanced by the addition of vinorelbine. This evidence concerns the gene FGFR4 and hepatocellular carcinoma.